SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001626199-23-000067
Filing Date
2023-04-28
Accepted
2023-04-28 16:51:32
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 s-3_20230428.htm S-3 852659
2 EX-FILING FEES alpn-ex107_20230428.htm EX-FILING FEES 50158
3 EX-1.2 alpn-ex12_20230428.htm EX-1.2 302286
4 EX-4.3 alpn-ex43_20230428.htm EX-4.3 426005
5 EX-5.1 alpn-ex51_20230428.htm EX-5.1 33893
6 EX-23.1 alpn-ex231_20230428.htm EX-23.1 2605
7 image_01.jpg GRAPHIC 7532
8 image_0a.jpg GRAPHIC 7526
9 picture1.jpg GRAPHIC 8445
  Complete submission text file 0001626199-23-000067.txt   1701484
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271517 | Film No.: 23867661
SIC: 2834 Pharmaceutical Preparations